Cosmos Study November 19, 2024 Dual-Team Study Team A:Dave Little, MDJoe Deckert, PhD Team B:Kersten Bartelt, RNJoe Longo Key Findings Patients with hypothyroidism who lose more than five pounds after starting a GLP-1 medication experience on average a 0.36 mU/L to 0.55 mU/L reduction of their thyroid-stimulating hormone (TSH) levels
GLP-1s and Your Stomach: The Challenge The peptide nature of this hormone is why developing effective oral versions of GLP-1 medications has been so challenging, says Dr
Even if treatment is considered medically necessary, it may be denied initially, forcing patients to submit formal, time-consuming appeals to get coverage
As research continues, these medications may become an important tool for managing a wide range of conditions, from metabolic and cardiovascular health to neuroinflammation and mast cell disorders
Northern Kentucky patients also have options across the river in Florence and Covington